Cargando…
Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
A series of phthalimide derivatives planned as drugs candidates to treat the symptoms of sickle cell anemia were evaluated in a mutagenicity test using strains of Salmonella typhimurium TA100 and TA102, without and with addition of S9 mixture, with the aim to identify the best structural requirement...
Autores principales: | dos Santos, Jean Leandro, Varanda, Eliana A., Lima, Lídia Moreira, Chin, Chung Man |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852868/ https://www.ncbi.nlm.nih.gov/pubmed/20386668 http://dx.doi.org/10.3390/ijms11020779 |
Ejemplares similares
-
Mutagenicity and antimutagenicity of (−)-hinokinin a trypanosomicidal compound measured by Salmonella microsome and comet assays
por: Resende, Flávia Aparecida, et al.
Publicado: (2012) -
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
por: dos Santos, Jean Leandro, et al.
Publicado: (2011) -
Origanum majorana Essential Oil Lacks Mutagenic Activity in the Salmonella/Microsome and Micronucleus Assays
por: Dantas, Andrea dos Santos, et al.
Publicado: (2016) -
Assessment of the Mutagenicity of Sediments from Yangtze River Estuary Using Salmonella Typhimurium/Microsome Assay
por: Liu, Li, et al.
Publicado: (2015) -
Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
por: Szyba, K, et al.
Publicado: (1983)